Skip to content
Venture Capital View site

Recent Posts

  • Glacier’s Edge
  • Deferred Thursday Tweets — TBH, I have trouble arguing against "unvaccinated sperm is the next Bitcoin"
  • 368. From a Bar Owner to $100M+ ARR, How an Outsider Navigated Silicon Valley, Raising through Peaks and Troughs of Hype Cycles, and How to Select $B startups at the Incorporation Stage (Oz Alon & Nadav Eylath)
  • Population and big innovations
  • AI and the HyperEncabulator

Most Used Categories

  • Digital Article (1,768)
  • Fundings & Exits (1,165)
  • Startups (1,089)
  • TC (679)
  • Posts (600)
  • Venture Capital (442)
  • entrepreneurship (404)
  • Audio (385)
  • Funding (351)
  • Recent Funding (314)
  • Facebook
  • Twitter
  • LinkedIn
  • Facebook
  • Twitter
  • LinkedIn

Venture Capital

a s.erious.ly site

  • Home
  • That Was The Week
  • Archimedes Accelerator
  • SignalRank
  • Keith Teare
  • Home
  • »
  • 2021
  • »
  • October
  • »
  • 1
  • »
  • The U.S. Can Lower Drug Prices Without Sacrificing Innovation
  • »

The U.S. Can Lower Drug Prices Without Sacrificing Innovation

October 1, 2021October 2, 2021 by David Blumenthal

This post is by David Blumenthal from HBR.org


Large pharmaceutical companies are nowhere near as important to real drug innovation as they purport to be.

Facebook Twitter Pinterest Linkedin

Post navigation

How to Scale Your Cybersecurity With Your Business
The World’s Top Coffee Producing Countries

Related Posts

Genpact CEO Tiger Tyagarajan: AI Is Getting Good, But Still Can’t Replace Human Curiosity

January 27, 2023

What Do You Like About Your Job?

January 27, 2023

When Your Feelings Conflict with Your Leadership Role

January 27, 2023
© All Rights Reserved 2021 WordPress | Theme : Peruse By Template Sell.
  • Home
  • That Was The Week
  • Archimedes Accelerator
  • SignalRank
  • Keith Teare
%d bloggers like this: